Mobio Interactive welcomes healthcare veteran Michael Meissner to Growth Advisory Board
Mobio Interactive welcomes healthcare veteran Michael Meissner to Growth Advisory Board
April 9, 2024 (Singapore) – Mobio Interactive, leading innovator in digital health, proudly announces Michael Meissner as its newest Growth Advisory Board member. This strategic addition underscores Mobio Interactive's commitment to revolutionising mental health measurement and treatment through cutting-edge technology. With a career spanning important roles at industry giants such as Medtronic and Sanofi, Michael brings a wealth of experience and valuable insight to his new role. Michael's appointment signifies a pivotal moment in Mobio Interactive's growth trajectory, as the company continues to expand its footprint and make significant strides in the global mental healthcare landscape.
In expressing his enthusiasm, Michael Meissner stated, “Mobio Interactive's vision of harnessing technology to empower individuals and transform mental health interventions is not only inspiring but has the potential to truly be game changing. Validated neurobehavioral interventions for patients with mental health challenges across many chronic diseases remains a domain lacking effective and scientifically proven solutions. Mobio Interactive's focus on the underlying neurobehavioral aspects is uniquely differentiated and I am excited to be joining the Mobio Interactive team in their vision and growth journey to bring solutions to mental health challenges.”
Michael Meissner boasts a rich and diverse professional journey, having served in pivotal roles that span the spectrum of healthcare innovation. As a former board member and chairman of the Scrum Alliance, he lent his expertise to empower agile change makers worldwide, facilitating the seamless integration of agile methodologies into corporations ranging from burgeoning startups to esteemed Fortune 500 entities.
During his tenure at Medtronic, Michael was General Manager for the Patient Management Business, orchestrating a global initiative to enhance cardiac implant offerings for patients and physicians alike. With a keen focus on optimising user experience and streamlining workflows, he spearheaded efforts to elevate the accessibility and efficacy of these critical solutions on a global scale.
Prior to Medtronic, Michael served as the Chief Technology Officer at Sanofi within the Medical Device Development group (MED). Here, he led pioneering efforts in digital drug delivery systems, leveraging data analytics to enhance patient compliance and outcomes across a spectrum of chronic and rare diseases. His innovative endeavors extended to a joint venture between UPMC and GE Healthcare, where he drove the transformation of traditional pathology departments into cutting-edge digital ecosystems. By implementing advanced slide scanning technologies and integrated workflow solutions, he revolutionised diagnostic processes, ensuring superior patient care.
Before his time at Sanofi, Michael was Vice President of Engineering at Vital Images (now a Toshiba company), where he championed the transition of radiology image review from two-dimensional to advanced three-dimensional platforms. His visionary leadership paved the way for enhanced diagnostic capabilities and superior patient outcomes.
Embarking on his entrepreneurial journey, Michael's inaugural venture in a virtual colonoscopy startup yielded groundbreaking results, as evidenced by a seminal study published in the New England Journal of Medicine. This early success underscored his unwavering commitment to leveraging technology to tackle healthcare's most pressing challenges. Driven by a profound belief in agility and armed with an innate entrepreneurial spirit, Michael remains steadfast in his dedication to crafting innovative solutions that address the evolving landscape of healthcare, with a relentless focus on overcoming workflow obstacles to drive success.
Dr. Bechara Saab, Mobio Interactive CEO & Chief Scientist, emphasised the profound impact Michael Meissner’s experience will have on the company’s Growth Advisory Board, stating, “As Mobio matures with multiple paying clients across several markets, it’s time for us to establish dedicated advisory boards. We’ve been working with Michael casually for years, even since Sanofi, and are happy to now be formalising our relationship by welcoming him to our Growth Advisory Board. Michael is expected to help us chart an efficient path to increasing revenues and margins, pulling from his high-level understanding of the healthcare market. Put more simply: Mobio has technology that no one else has, Michael’s job is to help us turn this uniqueness into impact and cash."
Michael’s induction into the board, alongside esteemed healthcare leaders such as Dr. Joseph Mocanu, Founder & Managing Partner at Verge HealthTech Fund, Dr. Annemiek Heijer, MD & former R&D Head at Zilveren Kruis Achmea, and Tony Estrella, Managing Director at Taliossa, marks a significant stride in Mobio Interactive's mission to redefine global mental healthcare accessibility.
About Mobio Interactive
Mobio Interactive is a digital health company that is meeting the exploding demand for efficacious mental healthcare with artificial intelligence-powered digital theragnostics.
For more information, visit mobiointeractive.com.
For more information on Michael Meissner, visit https://www.linkedin.com/in/michaelmeissner.